ORF Biologics, Inc. Announces Cutting-Edge Solutions for Biologics Design and Manufacturing

Tiffin, Iowa — [February 27, 2025] – ORF Biologics, a leading biotechnology company based in Tiffin, Iowa, is proud to announce its innovative approach to the design and manufacturing of both standard and custom biologics, including peptides, proteins, and antibodies. Under the leadership of CEO Anant Kamath, a seasoned industry expert with over 35 years of experience, ORF Biologics is positioned at the forefront of biopharmaceutical development, providing high-quality solutions that advance the future of medicine.

Founded with the mission to support pharmaceutical and biotechnology companies in their quest for next-generation therapeutics and research solutions, ORF Biologics offers a comprehensive suite of products and services. From early-stage discovery to large-scale production, the company specializes in tailoring biologics for a wide range of applications, including drug development, diagnostics, and personalized medicine.

“Biologics play a pivotal role in transforming healthcare, and ORF Biologics is committed to supporting the industry’s growth by delivering custom, scalable, and reliable solutions,” said Kamath. “With our intellectual property, cutting-edge technology and deep expertise, we are proud to collaborate with our clients to bring novel therapies and research tools to the market.”

ORF Biologics’ team of scientists and strategic partners employ state-of-the-art platforms to ensure the highest standards of purity, yield, and stability for every biologic they produce. The company is dedicated to offering flexible solutions for both small-scale and large-scale projects, meeting the unique needs of clients in a rapidly evolving market.

“Our experience and commitment to quality set us apart. Whether it’s a peptide, protein, or antibody, we strive to deliver biologics that exceed client expectations while supporting their R&D, clinical, and commercial objectives,” Kamath added.

With an increasing demand for biologics in the treatment of a variety of diseases, ORF Biologics remains a trusted partner to pharmaceutical companies, universities, and research institutions across the globe. The company continues to innovate, ensuring it remains a leading force in the biologics manufacturing sector.

For more information about ORF Biologics and its services, visit orfbiologics.com or contact:

Anant Kamath, CEO
ORF Biologics, Inc.
Phone: 319-992-0001
Email: contact@orfbiologics.com
Website: orfbiologics.com